Streetbeat News

Price Targets

BNTX

Canaccord Genuity analyst Bill Selesky reiterates a Buy rating on BioNTech (NASDAQ:BNTX) and maintains a $203 price target.

Portfolio Pulse from richadhand@benzinga.com

June 16, 2023 | 2:05 pm

AUR

Canaccord Genuity analyst George Gianarikas reiterated a Buy rating on Aurora Innovation (NASDAQ:AUR) and maintained a $5 price target.

Portfolio Pulse from richadhand@benzinga.com

June 16, 2023 | 2:04 pm

ASPN

Canaccord Genuity analyst George Gianarikas reiterated a Buy rating on Aspen Aerogels (NYSE: ASPN) and maintained a $14 price target.

Portfolio Pulse from richadhand@benzinga.com

June 16, 2023 | 2:02 pm

DOMO

In the last 3 months, 4 analysts have provided 12-month price targets for Domo (NASDAQ:DOMO), with an average price target of $27.5, up 30.95% from the previous average of $21. The ratings include 1 bullish and 3 somewhat bullish.

Portfolio Pulse from Benzinga Insights

June 16, 2023 | 2:02 pm

ALLO

Canaccord Genuity analyst John Newman has reiterated a Buy rating on Allogene Therapeutics (NASDAQ:ALLO) and maintained a $35 price target.

Portfolio Pulse from richadhand@benzinga.com

June 16, 2023 | 2:02 pm

NVDA

In the last 3 months, 49 analysts have provided 12-month price targets for NVIDIA (NASDAQ:NVDA), with an average price target of $410.76, a 36.32% increase from the previous average of $301.31. The ratings include 20 bullish, 25 somewhat bullish, 4 indifferent, and no bearish opinions.

Portfolio Pulse from Benzinga Insights

June 16, 2023 | 2:00 pm

CLNN

Benchmark analyst Bruce Jackson reiterates a Buy rating on Clene (NASDAQ:CLNN) and maintains a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

June 16, 2023 | 2:00 pm

ESTC

DA Davidson analyst Andrew Nowinski initiates coverage on Elastic (NYSE:ESTC) with a Neutral rating and announces a price target of $60.

Portfolio Pulse from richadhand@benzinga.com

June 16, 2023 | 1:59 pm

BNOX

Maxim Group analyst Jason McCarthy initiates coverage on Bionomics (NASDAQ:BNOX) with a Buy rating and announces a price target of $7.

Portfolio Pulse from richadhand@benzinga.com

June 16, 2023 | 1:57 pm

WST

Bank of America Securities upgraded West Pharmaceutical Services from Neutral to Buy and raised its price target from $390 to $405.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 1:51 pm